Literature DB >> 3574369

X-linked dilated cardiomyopathy.

B A Berko, M Swift.   

Abstract

To study the inheritance of idiopathic dilated cardiomyopathy, we investigated a large kindred in which 11 young male members had definite or possible evidence of the disorder. The five affected males for whom we had complete clinical data survived for 5 to 12 months after the onset of symptoms, which occurred early in life (ages 15 to 21 years). In six other males, clinical data were incomplete but suggested possible cardiomyopathy. Three mothers of affected males were given a diagnosis of definite, and two of possible, late-onset dilated cardiomyopathy. These women presented in their 40s with atypical chest pain, and progressive congestive heart failure developed gradually over a period of 10 or more years. X-linked inheritance of dilated cardiomyopathy is suggested in this family by the early onset in males, late onset in females, and no evidence of male-to-male transmission. The late onset of the disease in females, in contrast to the early onset in hemizygous males, is compatible with heterozygosity for the mutant allele. Since most cases of genetically lethal X-linked syndromes appear to be sporadic, for every case of "idiopathic" dilated cardiomyopathy in which X-linked inheritance can be confirmed from family information, it is possible that there are several nonfamilial cases due to a mutation at the same locus.

Entities:  

Mesh:

Year:  1987        PMID: 3574369     DOI: 10.1056/NEJM198705073161904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Heart failure. Symposium proceedings. 21-24 April 1998.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

3.  Up-regulation of the brain and Purkinje-cell forms of dystrophin transcripts, in Becker muscular dystrophy.

Authors:  A Nakamura; S Ikeda; M Yazaki; K Yoshida; O Kobayashi; N Yanagisawa; S Takeda
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 4.  Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.

Authors:  Giuliana G Repetti; Christopher N Toepfer; Jonathan G Seidman; Christine E Seidman
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 6.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

7.  X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome.

Authors:  A K Gedeon; M J Wilson; A C Colley; D O Sillence; J C Mulley
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

Review 8.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

9.  Dystrophin analysis in idiopathic dilated cardiomyopathy.

Authors:  V V Michels; G M Pastores; P P Moll; D J Driscoll; F A Miller; J C Burnett; R J Rodeheffer; J A Tajik; A H Beggs; L M Kunkel
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

10.  Danon disease presenting with dilated cardiomyopathy and a complex phenotype.

Authors:  Matthew R G Taylor; Lisa Ku; Dobromir Slavov; Jean Cavanaugh; Mark Boucek; Xiao Zhu; Sharon Graw; Elisa Carniel; Carl Barnes; Dianna Quan; Ryan Prall; Mark A Lovell; Gary Mierau; Patsy Ruegg; Naresh Mandava; Michael R Bristow; Jeffrey A Towbin; Luisa Mestroni
Journal:  J Hum Genet       Date:  2007       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.